A Clinical Study to Compare MAR-CUTIS With Dermabond Advanced

NATerminatedINTERVENTIONAL
Enrollment

107

Participants

Timeline

Start Date

October 30, 2018

Primary Completion Date

July 17, 2019

Study Completion Date

September 4, 2019

Conditions
Wounds and InjuriesLacerationsSurgical Incision
Interventions
DEVICE

MAR-CUTIS

MAR-CUTIS was applied in 1 to 2 mm thick layer, ensuring that at least 1 cm of the glue was applied over the length of the wound on each side. The amount of the glue applied was calculated such that one 5-mL syringe covers approximately 8 cm of wound length (giving a total of 10 cm per syringe). For wounds \>8 cm, 2 syringes were required.

DEVICE

Dermabond Advanced

Dermabond Advanced was applied in 1 continuous layer onto a dry wound through painting motions, taking care not to apply adhesive between the wound edges.

Trial Locations (19)

13353

010 - Charité Berlin, Berlin

28007

022 - Hospital General Universitario Gregorio Maranon, Madrid

39130

009 - Klinikum Magdeburg, Magdeburg

41013

003 - University Hospital Virgen del Rocío, Seville

69120

006 - Universitätsklinikum Heidelberg, Heidelberg

80054

004 - CHU Amiens-Picardie, Amiens

94500

005 - Hôpital Privé Paul d'Egine, Champigny-sur-Marne

08035

001 - Hospital Universitari Vall d'Hebron, Barcelona

S75 2EP

019 - Barnsley Hospital, Barnsley

B4 6NH

017 - Birmingham Children's Hospital, Birmingham

BS2 8AE

018 - Bristol Royal Hospital for Children, Bristol

CF14 4XW

021 - University Hospital of Wales, Cardiff

CM20 1QX

013 - The Princess Alexandra Hospital, Harlow

LS9 7TF

011 - Leeds Teaching Hospitals, Leeds

SW17 0QT

016 - St George's Hospital, London

CT9 4AN

014 - Queen Elizabeth the Queen Mother Hospital, Margate

NP20 2UB

020 - Royal Gwent Hospital, Newport

PE3 9GZ

012 - Peterborough City Hospital, Peterborough

TA1 5DA

015 - Musgrove Park Hospital, Taunton

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Syneos Health

OTHER

lead

Grünenthal GmbH

INDUSTRY